Winston J. Churchill, Director at Baudax Bio, Inc. (BXRX), bought 100,000 shares at $0.63 ($63K) on 2021-08-31, disclosed to the SEC on 2021-08-31.
Open-market purchase of $63k BXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AMKR | SELL | 2025-12-17 | $221K | — | Filing → |
| AMKR | SELL | 2024-08-29 | $659K | — | Filing → |
| AMKR | SELL | 2024-03-08 | $862K | — | Filing → |